FMP
Collegium Pharmaceutical, Inc.
COLL
NASDAQ
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
34.74 USD
-0.1 (-0.288%)
About
ceo
Mr. Joseph J. Ciaffoni
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.collegiumpharma.com
exchange
NASDAQ
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
CIK
0001267565
ISIN
US19459J1043
CUSIP
19459J104
Address
100 Technology Center Drive
Phone
781 713 3699
Country
US
Employee
197
IPO Date
May 7, 2015
Summary
CIK
0001267565
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
19459J104
ISIN
US19459J1043
Country
US
Price
34.74
Beta
1.04
Volume Avg.
406.39k
Market Cap
1.11B
Shares
-
52-Week
20.83-40.95
DCF
47.97
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
26.93
P/B
-
Website
https://www.collegiumpharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest COLL News
It looks like there's no news available.
